The emerging therapy of the medication represents a major development in the management of type 2 diabetes. Different to existing medications, tirzepatide affects dual pathways – GLP-1 and GIP – leading to enhanced https://tirzepatide-peptide437770.blogtov.com/22711667/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment